FDA broadens reach of GE HealthCare’s amyloid imaging agent Vizamyl in Alzheimer’s diagnostics
The FDA expanded the uses of GE HealthCare’s Vizamyl imaging agent for highlighting the presence of beta amyloid proteins in...
The FDA expanded the uses of GE HealthCare’s Vizamyl imaging agent for highlighting the presence of beta amyloid proteins in...
Austin, May 13, 2025 (GLOBE NEWSWIRE) -- Veterinary Diagnostics Market Size & Growth Analysis: According to SNS Insider, the Veterinary...